Around 2 million women are affected by Breast cancer every year. Triple-negative breast cancer (TNBC) represents around 10-20% of the total Breast cancer cases. The Triple-Negative Breast Cancer tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein.
An increase in age, previous breast cancer diagnosis, reproductive history, radiation exposure, lifestyle habits such as alcohol consumption, cigarette smoking, obesity, or genetic aberrations (BRCA-1 and BRCA-2 mutations) are some of the key factors for the occurrence of Triple-Negative Breast Cancer.
It is being observed that Triple-negative breast cancer is comparatively aggressive and has a higher chance to spread to other sites in the body. However, with the kind of research and development going on in the Triple-negative breast cancer therapeutic market, it is likely going to ease the burden of this disease in the coming years.
To read more about the Key Facts on Triple-Negative Breast Cancer, visit: https://www.delveinsight.com/blog/key-facts-to-know-about-triple-negative-breast-cancer-tnbc/